Abstract. The development of sarcomas in smallpox vaccination scars is very rare. Including this case, only five have been reported. This is the first report of a leiomyosarcoma arising in a smallpox vaccination scar.
Case report
A 33-year-old female was vaccinated against smallpox on her left deltoid area. Five years later in 1976, a painful nodule 1.5 cm in diameter developed in the scar. The clinical diagnosis was a hypertrophic scar. It was excised but six years later it recurred and was again excised (1982) . A second recurrence was excised in 1987. Histology confirmed the clinical diagnosis of scar hypertrophy.
Four months after this a painful nodule appeared. Six years later 1993, because of patient delay, a biopsy revealed a leiomyosarcoma. MRI and CT scans (Figs. 5, 6 ) determined the extent of the tumor and the patient was referred to us.
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There was a 6 cm in diameter painful mass ( Fig. 1 ) with a 1 cm nodule in the oblique scar of her left shoulder. The tumor was widely excised with the superficial portion of the underlying deltoid, the defect being 10.5 cm in diameter (Fig. 2) . A split thickness skin graft was applied.
A biopsy of a scar-like structure in the skin transplant revealed another recurrence in October 1995. Resection of the deltoid muscle and musculocutaneous reconstruction, supplemented by pre-and postoperative radiotherapy was proposed but rejected by the patient.
Investigations
• Preoparative CT scans showed a lobular mass on the left deltoid area measuring 5 cm in the anteroposterior and 4 cm in the laterolateral scan (Fig. 5) . It was located in the subcutaneous tissue, infiltrating the cutis with elevation of the overlying scar and adjacent skin. No local and regional adenopathy was present.
• Preoperative MRI confirmed the CT scan findings (Fig. 6 ). The superficial muscle fibers of the deltoid were infiltrated.
• Histology showed proliferated spindle-shaped cells with abundant eosinophilic, fibrillar cytoplasm. Polymorphism was rare. Mitotic rate was 15-20 per 10 HPF (x400) (Fig. 7) . The leiomyosarcoma was mainly located in the subcutis. It infiltrated the dermis superficially and deeply spot-like in the deltoid muscle (Fig.  8) . Histology of the overlying dermis showed characteristics of scar hypertrophy (preceding excisions and biopsies). Diagnosisgrade II sarcoma.
• Immunohistochemistry confirmed the presence of muscle specific actin and desmin, but absence of cytokeratin and vimentin.
Discussion
Malignant tumors arising in smallpox vaccination scars are rare. The first was reported in 1943 [7] , and 70 cases, including our one, have been described [8] . Of these, 48 were male and 22 female, 58% after primary vaccination, 25% after revaccination, and 17% unknown. The mean age of patients was 53 years, the youngest patient being 15, the oldest 81. The mean latent period (interval between vaccination and onset of the lesion or consulting a physician) was 25 year. Three patients were Black, the majority were Causacians. Risk factors were long- term physical irritation such as sun exposure or chronic scarring, the treatment of choice was local excision [8] .
Fifty-seven percent of malignancies in smallpox vaccination scars were basal cell carcinomas. The male to female ratio was 3:1. The mean age of patients was 54 years. The mean latent period was 24 years [8] .
Twenty-two percent of all reported malignancies in smallpox vaccination scars were malignant melanomas. The male to female ratio was 3:2. The mean age of patients was 49 years, 50% arising between 39 and 58 years. The mean latent period was 22 years [8] .
Fourteen percent of all reported malignancies in smallpox vaccination scars were squamous cell carcino-mas. The male to female ratio was 2; 1. The mean age of patients was 55 years. The mean latent period was 19 years [81.
Seven percent of all reported malignancies in smallpox vaccination scars were sarcomas. This represented five cases, one fibrosarcoma, two dermatofibrosarcomas protuberans, one malignant fibrohistiocytoma, and this leiomyosarcoma.
